Table 2:

Grade 3 or 4 adverse events for the 220 evaluable patients treated with FAS

Adverse event	N=220 N (%)
Hematologic
Neutropenia	22 (10)
Thrombocytopenia	3 (1.4)
Anemia	2 (0.9)
Gastrointestinal
Nausea/vomiting	12 (5.5)
Oral Mucositis	8 (3.6)
Diarrhea	11 (5)
Fatigue	6 (2.7)
Blood glucose
Hypoglycemia	2 (0.9)
Hyperglycemia	5 (2.3)
Anorexia	4 (1.8)
Cardiac	3 (1.4)
Fever	3 (1.4)
Elevated serum creatinine	2 (0.9)
Edema	2 (0.9)
Hepatic
Elevated liver enzymes	1 (0.5)
Hand-foot syndrome	1 (0.5)
Pancreatitis	1 (0.5)